Aneta Nowicka, Edyta Szałek, Lidia Gil, Martin Sima, Agnieszka Karbownik
Midostaurin – the first targeted therapy drug for patients with acute myeloid leukaemia with FLT3 mutation
2023-02-13
Midostaurin – the first targeted therapy drug for patients with acute myeloid leukaemia with FLT3 mutation
341.06 kB |
3 marca 2023